Home LiteratureArticle Details

PMID: 8284019 Published · ppublish English Clinical Trial Letter Multicenter Study Randomized Controlled Trial

Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.

The New England journal of medicine ·Vol. 330 ·No. 6 ·1994-02-10 ·Pages 438-9

Shafran SD, Deschênes J, Miller M, Phillips P, Toma E

Abstract

暂无摘要

MeSH Terms

AIDS-Related Opportunistic Infections/drug therapy Bacteremia/drug therapy Clarithromycin/administration & dosage,therapeutic use Drug Therapy, Combination Ethambutol/administration & dosage,therapeutic use Humans Jaundice/chemically induced Mycobacterium avium-intracellulare Infection/drug therapy Prospective Studies Rifabutin/administration & dosage,adverse effects Uveitis/chemically induced

Chemicals

Rifabutin Ethambutol Clarithromycin

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Shafran S D

Deschênes J

Miller M

Phillips P

Toma E

Article Info

Journal

The New England journal of medicine

Abbr.

N Engl J Med

ISSN

0028-4793

DOI

10.1056/NEJM199402103300616

Published

1994-02-10

Pages

438-9

Language

English

Region

United States

NLM ID

0255562

Subset

External Links

PubMed source DOI: 10.1056/NEJM199402103300616 View journal details

Analysis Services

Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.

Contact

WeChat Official Account